Registry for pediatric bipolar disorder in the Greater Houston Area
Official title: Greater Houston Area Pediatric Bipolar Registry
Run by The University of Texas Health Science Center, Houston · NCT06665984 · Data updated 2026-11-12
This study is looking at children and teens with bipolar disorder, their siblings, and healthy kids to see how their genes and brain structures relate to mood changes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 6 Years to 17 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | The University of Texas Health Science Center, Houston Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | December 6, 2022 |
| Main results expected | December 6, 2027 |
| Study ends | December 6, 2046 |
| Registry record updated | February 18, 2026 |
| Trial ID | NCT06665984 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include children and adolescents meeting DSM-V criteria for bipolar disorder, offspring of parents with bipolar disorder, and healthy controls.
✕Probably not a fit
Patients with autism spectrum disorder, severe neurological disorders, or significant medical problems may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess children and adolescents diagnosed with bipolar disorder, those who are offspring of parents with bipolar disorder, and healthy controls. Participants will provide blood and saliva samples for the evaluation of biomarkers and genetic information related to bipolar disorder. Additionally, the study will utilize MRI techniques to investigate brain structures and pathways linked to mood regulation and the progression of bipolar disorder. The research also aims to inform participants about future studies they may qualify for and recommend follow-up care if necessary.
Why it matters
Potential benefit: If successful, this study could lead to better understanding and early identification of pediatric bipolar disorder, potentially improving treatment outcomes.
How similar studies have gone: While there have been studies on pediatric bipolar disorder, this registry approach focusing on biomarkers and MRI is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for bipolar patients or offspring of bipolar parents: * Any current mood state (in the case of bipolar subjects) * For bipolar patients: DSM-V criteria for BD type I, BD type II, or BD NOS, as per the administration of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID) * For the offspring of bipolar parents: at least one parent meeting DSM-V criteria for BD type I or BD type II, or BD NOS as per the administration of the MINI Adult Exclusion Criteria for bipolar patients or offspring of bipolar parents: * Autism Spectrum Disorder (ASD) * Developmental Intellectual Disorder * Severe Neurological Disorder that affects cognitive status (e.g., epilepsy, traumatic brain injury, tubular sclerosis) * Schizophrenia * Uncontrolled or severe medical problem per investigator judgment * For the offspring: parents with a history of any brain diseases, including seizures, stroke, meningitis, encephalitis, dementia, and other degenerative brain diseases; parents with a history of intellectual disability Exclusion Criteria for healthy control subjects: * Any Psychiatric Diagnosis * Any family history of Bipolar Disorder, Psychotic Disorder, Schizophrenia, or Schizoaffective disorder in a first-degree relative * Any family history of a neurological condition in a first-degree relative. * Mental Retardation/Intellectual Disability * Severe Neurological Disorder that affects cognitive status (e.g., epilepsy, traumatic brain injury, tubular sclerosis) * Schizophrenia * Uncontrolled or severe medical problem per investigator judgement Exclusion criteria for annual visits: * Autism Spectrum Disorders (ASD) * Intellectual Developmental Disorder * Severe Neurological Disorder that affects cognitive status (e.g., epilepsy, traumatic brain injury, tubular sclerosis) * Schizophrenia * Uncontrolled or severe medical problem per investigator judgement
Where it's running
-
The University of Texas Health Science Center at Houston
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Jair C Soares, M.D. PhD — The University of Texas Health Science Center, Houston
- Study coordinator: Jair C Soares, M.D. PhD
- Email: utmooddisorders@uth.tmc.edu
- Phone: (713) 486-6663
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of comorbidity on people with severe mental illness
This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.
-
Venous Tourniquet with Low-Dose Sugammadex vs Arterial Tourniquet for Seizure Monitoring During ECT
40 patients undergoing ECT will have a venous tourniquet on one arm and an arterial tourniquet on the other to see which method better reveals motor seizures.
-
7T MRI and visual perception markers for severe mood and psychotic disorders
This project tests whether 7‑tesla MRI scans combined with visual perception tests can identify brain markers linked to diagnosis and treatment outcomes in adults with major depressive disorder, bipolar disorder, or schizophrenia.
-
Emotional Eating, Sleep Quality, Mental State, and Metabolic Syndrome in Psychiatric Patients
This study tests how mood, sleep, and emotional eating relate to metabolic syndrome in people with schizophrenia or bipolar disorder.
-
À deux, c'est mieux — group program to improve romantic relationships for young adults with severe mental illness
This program will try a 12-week, small-group course to help single adults with severe mental illness build skills for dating, communication, and closer social relationships.
-
Brenipatide for adults with bipolar disorder (RENEW-Bipolar-1)
This trial will test whether adding brenipatide to standard bipolar medications can delay worsening of symptoms in adults with bipolar I or II.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.